Association between cellular characteristics and clinical outcomes following autologous micro-fragmented adipose tissue injection for knee osteoarthritis.
Fan C., Zhao Z., Liang B., Xing Y., Li S., Xiao K.
Retrospective Study with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Front Bioeng Biotechnol (2026)
- Country
- Switzerland
- Reported sample size
- 40
- Source database
- PubMed
- PMID
- 42305813
- PMCID
- PMC13265573
- DOI
- 10.3389/fbioe.2026.1843722
Abstract (original English)
Autologous micro-fragmented adipose tissue (aMFAT) has emerged as a promising orthobiologic therapy for knee osteoarthritis (KOA). However, the relationship between the cellular characteristics of aMFAT products and clinical outcomes remains unclear. This retrospective single-center study included 40 patients with symptomatic KOA (Kellgren-Lawrence grade II-III) who received a single intra-articular injection of aMFAT. Clinical outcomes were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at baseline, 3 months, and 6 months. Cytological analyses were performed in a subgroup of 14 patients, including cell viability, total nucleated cell count, viable nucleated cell load, and cell subpopulation composition. Subgroup and correlation analyses were conducted to explore associations between cellular characteristics and clinical outcomes. Significant improvements in WOMAC total and subscale scores were observed at both 3 and 6 months compared with baseline (P < 0.05). At 6 months, 97.5% of patients achieved the minimal clinically important difference. In the cytological subgroup, both cell viability and viable nucleated cell load were positively correlated with clinical improvement, with viable nucleated cell load demonstrating a stronger association (r = 0.93 vs. 0.84). Patients with higher cell load showed significantly greater and more sust
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Clinical Outcomes of Biologic Therapies for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Studies With ≥12-Month Follow-up.
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, published in Mod Rheumatol (2026) — summary generated from the PubMed abstract.
- 2026
Mod Rheumatol - Level AMeta-analysisEurope PMC
Towards optimized rehabilitation with regenerative therapy: A systematic review and meta-analysis on the effects of cell-based injections for knee osteoarthritis
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, published in Knee Surg Sports Traumatol Arthrosc (2026) — summary generated from the PubMed abstract.
- 2026
Knee Surg Sports Traumatol Arthrosc - Level ASystematic ReviewPubMed
Intra-articular fat grafting for pain relief and functioning improvement in patients with knee osteoarthritis: systematic review.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, published in Disabil Rehabil (2026) — summary generated from the PubMed abstract.
- 2026
Disabil Rehabil - Level ASystematic ReviewPubMed
Research Landscape of Stem Cell Applications in Musculoskeletal Tissue: A Scoping Review.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisEurope PMC
Influence of platelet-rich plasma composition on pain and functional performance in knee osteoarthritis: a systematic review and network meta-analysis
Meta-analysis with a reported sample of 5251 on Knee Osteoarthritis, Osteoarthritis, published in Knee Surg Relat Res (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5251
Knee Surg Relat Res